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Abstract 
Nicotine, main constituent of tabaco, is known as a nicotinic acetylcholine receptor (nAChR) 
agonist and increases cognitive performance. 3-(2,4-dimethoxybenzylidene)-anabaseine (GTS-21) is 
derived from the marine worm toxin, anabaseine, and is alpha7-selective nAChR (D7-nAChR) 
agonist. Both nicotine and GTS-21 were expected as therapeutic agents of Alzheimer’s disease. 
Several studies showed that nicotine and GTS-21 protected neuron by activating nAChR, especially 
D7-nAChR. It has been reported that D7-nAChR has been shown to be an essential regulator of 
inflammation. The purpose of this study is to examine the neuroprotective and anti-inflammatory 
effects of nicotine and GTS-21 using organotypic hippocampal slice cultures. Kainic acid (KA, 5-50 
ȝM) induced concentration- and time-dependent neuronal cell death in the hippocampal organotypic 
slice cultures. The pretreatment with nicotine and GTS-21 tended to decrease in KA toxicity. In a CA3 
area-specific analysis, pretreatment with nicotine resulted in significant inhibition of KA-induced 
neurotoxicity. The results suggest that nicotine may protect KA-induced neuronal cell death via 
D7-nAChR. We also examined anti-inflammatory effects of nicotine and GTS-21. Hippocampal slices 
were pretreated with nicotine or GTS-21, and then treated with lipopolysaccharide (LPS). LPS 
treatment induced concentration-dependent increases in TNFD and IL-1E gene expressions. 
LPS-induced TNFD gene expression, but not IL-1E was suppressed by GTS-21 pretreatment. These 
results suggest that D7-nAChR might be involved in the microglia activation towards a 
neuroprotective role by suppressing inflammatory cytokine. 
㩷
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Introduction  
   Organotypic hippocampal slice cultures have recently 
employed in the study of toxicological or disease oriented 
neurodegeneration. The hippocampus plays a key role in 
learning and memory, and thus it pays great attention in the 
study of neurodegenerative disorders. Since the primary culture 
of neuron destroys the environment for nerve and glial cells, it 
is difficult to reproduce their functions based on the intrinsic 
morphology of nerve, nerve activity or release of 
neurotransmitters. There is only electrophysiological method 
using slice section for evaluation of nerve activity. While, the 
hippocampal slice cultures make it possible to be cultivated 
under maintenance of neuron’s morphology and function of 
neuron, and ganglionic layer in the hippocampus 1). 
Furthermore, the organotypic hippocampal slice cultures are 
able to control their surroundings artificially, therefore, 
environments are easily modified by complying with the 
experimental purpose. Therefore, the organotypic hippocampal 
slice cultures are expected to be useful for in vitro study on 
effect of pharmacological or toxic agents on nerves system.  
Nicotine, a main constituent of tabaco, is known to show a 
variety of pharmacological activities through nicotinic 
acetylcholine receptor (nAChR) in central and peripheral 
nervous system. A negative correlation is suggested between 
cigarette smoking and the incidence of Parkinson’s disease or 
Alzheimer’s disease 2), and nicotine is suggested to be a 
therapeutic agent for neurodegenerative diseases. Neurotoxicity 
or behavior disorders induced by glutamate receptor agonists 
including kainic acid (KA), glutamate and 
N-methyl-D-aspartate (NMDA) etc. have been reported to be 
inhibited by nicotine 3,4,5,6). Therefore, neuroprotective effect of 
nicotine has been noted, and nAChR is thought to be engaged 
in this effect. nAChR consists of various subunits, and it has a 
wide distribution in the brain and peripheral nerves. Both Į4ȕ2 
and Į7 subunits are widely distributed especially in the brain 7), 
most notably Į7-nAChR is calcium-permeant channel 8,9), and 
it is known to be distributed in high density in the area relevant 
to learning and memory including hippocampus 10,11,12). 
   3-(2, 4-dimethoxybenzylidene) anabasein (GTS-21), a 
synthetic nicotinic agonist was developed related to a 
compound, anabasein which produced by certain marine worms 
13,14). While benzyliden anabasein compounds have shown to be 
useful for the elucidation of nAChR drug-receptor 
structure-function relationships 15).  It has reported that Į7 
receptor activation is sufficient to improve both avoidance and 
spatial memory task 11). Furthermore, when the roles of 
intracellular calcium ions and downstream of calcium channels 
in neuroprotection are assessed, Į7 receptor activation is 
essential for cytoprotection against trophic factor deprivation, 
and protracted elevation in intracellular calcium ion is essential 
for such protection 16). GTS-21 is expected to be a promising 
therapeutic agent for neurodegenerative diseases including 
Alzheimer’s disease 17,18) and Schizophrenia 19,20,21). In this 
study, we examined the effect of nicotine and GTS-21 on some 
neurotoxic chemicals, aiming at elucidating neuroprotective 
action by Į7-nAChR. KA-induced neurotoxicity in the 
hippocampal slice cultures is reported to produce selectively 
neuronal cell death in CA3 area 22). Based on these findings, we 
examined whether nicotine and GTS-21 is able to inhibit this 
specific neurotoxicity induced by KA in CA3 area. 
Although the expression of Į7-nAChR is thought to be 
predominant in nerve cells, it has recently become evident in 
various non-nerve cells including immune cells 23). Į7-nAChR 
is identified in monocyte and Į7-nAChR-mediated nicotine 
inhibits the release of tumor necrosis factor alpha (TNFĮ) from 
macrophages 24). Microglia works as immune cells in the 
central nervous system (CNS), and it shows opsonic action by 
activation, and it thus contributes to neuronal degeneration 25, 
26). Activated microglia in these processes produces and 
releases inflammatory cytokines such as interleukin-1ȕ (IL-1ȕ) 
and TNFĮ 27, 28), and results in production of ROS including 
nitric oxide (NO). These actions produced by activated 
microglia, are thought to be a cause of neurodegenerative 
disorders through damage to normal cells. Therefore, it is 
interested to clarify whether Į7-nAChR in microglia affects the 
production of inflammatory cytokines. In the present study, we 
examined the effects of nicotine and GTS-21 on 
lipopolysaccharide (LPS)-stimulated IL-1ȕ and TNFĮ gene 
expressions in order to elucidate whether Į7-nAChR is 
involved in functional regulation of microglia.  
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Methods 
1. Materials and animals 
   GTS-21 was generously provided by Dr. William Kem of 
the University of Florida. The figure 1 shows chemical 
structures of nicotine and GTS-21 used in this study. LPS (from 
Escherichia coli serotype 055:B5) were obtained from 
Sigma-Aldrich (St. Louis, MO). All other chemicals were 
analytical or of the highest grade commercially available. All 
animal experiments were conducted under the Showa 
University Animal Experiment and Welfare Regulations. Three 
days old Wistar rats were purchased with mother from Japan 
Laboratory Animal, Inc (Tokyo, Japan). 
 
2. Preparation of organotypic hippocampal slice cultures 
   Organotypic hippocampal slice culture was prepared as 
described previously 29). Seven days old rats were killed by 
decapitation and their brains were removed. The hippocampal 
slices were prepared by Mcllwain tissue chopper into 400 ȝm 
thick. Three of slices were placed on culture plate insert 
(Millicell-CM, 0.4 ȝm, Billerica, MA) and transferred to six 
well culture plate with 1 ml of MEM supplemented with 25% 
horse serum, 6.5 mg glucose and 0.5 mM glutamine. Culture 
was maintained at 32oC and the medium was changed every 
2-3 days.  
 
3. Drug treatment and assessment of neuronal cell death 
   Effects of nicotine and GTS-21 were tested in mature 
cultures, which had been maintained for 15-21 days. Slice 
cultures exposed to nicotine and GTS-21 for 12 hr followed by 
kainic acid treatment for 24 hr. And then neuronal cell death 
was assessed by propidium iodide (PI) uptake. The medium 
was changed to Locke solution [154 mM NaCl, 5.6 mM KCl, 
2.3 mM CaCl2, 3.6 mM NaHCO3, 5 mM Hepes, pH 7.4] and 
then added PI solution to the medium (final conc. 50 ȝg/ml). At 
30 min after the addition of PI solution, neuronal cell death was 
assessed by microscopic observation (BZ-8000, KEYENCE, 
Osaka, Japan). The intensity of fluorescence was quantitatively 
analyzed using VH-H1A5 analyzer (KEYENCE). The mean ± 
S.E.M. of the fluorescence intensity in each group was 
calculated and the values are expressed as relative percentages 
of those in the only KA-treated group. 
4. LPS treatment and inflammatory cytokine gene 
expressions  
   Slice cultures were exposed to nicotine and GTS-21 for 12 
hr followed by LPS treatment for 3 hr. Three hippocampal 
slices were placed on one tube and then total RNA were 
extracted using the QIAGEN RNeasy Lipid Tissue Mini kit 
(QIAGEN, Hilden, Germany). Real time RT-PCR was carried 
out by QuantiTect SYBR Green RT-PCR (QIAGEN). Primers 
for IL-1ȕ, TNFĮ and GAPDH were prepared by QuantiTect 
Primer Assays (QIAGEN). Amplification conditions were of 40 
cycles of 94oC for 15 s, 55oC for 30 s and 72oC for 30 s. mRNA 
expression was normalized using GAPDH as an endogenous 
control.  
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㪝㫀㪾㪅㩷㪈㪅㩷Structures of nicotine and GTS-21.㩷
 
5. Statistical analysis 
Statistical analysis was performed with Dunnett’s test. 
Results 
1. KA-induced neurotoxicity  
   Neurotoxicity induced by KA which was an agonist of 
glutamate receptors was assessed in areas of CA1, CA3 and 
dendate gyrus (DG) in the hippocampal slices (Fig. 2A top 
panel). Selective cell death in pyramidal cell layer of CA3 area 
was observed by the treatment with 5 and 10 ȝM KA. When 
slices were treated with more higher concentration of KA, cell 
death was observed in not only CA3 area, but also the 
pyramidal cell layer of CA1 and granular cell layer of DG area 
(Fig. 2A). KA-induced cell death in hippocampus was induced 
in a concentration-dependent manner.  
   Figure 2B shows the time course of 20 ȝM KA-induced 
neurotoxicity. Cell death was not observed in the hippocampal 
Nicotine GTS-21 
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㪝㫀㪾㪅㩷㪉㪅㩷 Toxicity of KA in organotypic hippocampal slice cultures. Cell death was assessed at 48 hr after kainic acid treatment. 
Toxicity of KA was assessed on concentration- (a) and time-dependent analysis (b). Representative data from three 
different experiments are shown. Values are expressed as mean ± S.E.M.㩷
㩷
㩷
㩷
㪝㫀㪾㪅㩷㪊㪅㩷 Effect of nicotine on KA-induced neurotoxicity. Organotypic hippocampal slice culture were pretreated with nicotine for 
12 hr and followed by KA treatment for 24 hr. And then neuronal cell death was assessed by PI uptake in whole 
hippocampal area (a) and CA3 area (b). Representative data from three different experiments are shown. The mean ± 
S.E.M. of the fluorescence intensity in each group was calculated and the values are expressed as relative percentages of 
those in the only KA-treated group. **p<0.01 compared with the KA-treated group.㩷
㩷
㩷
㩷
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㪝㫀㪾㪅㩷㪋㪅㩷 Effect of GTS-21 on KA-induced neurotoxicity. Organotypic hippocampal slice cultures were pretreated with GTS-21 for 
12 hr and followed by KA treatment for 24 hr. And then neuronal cell death was assessed by PI uptake in whole 
hippocampal area (a) and CA3 area (b). The mean ± S.E.M. of the fluorescence intensity in each group was calculated and 
then the values are expressed as relative percentages of those in the only KA-treated group.㩷
㩷
㩷
㩷
㪝㫀㪾㪅㩷㪌㪅㩷 LPS-induced inflammatory cytokine gene expression. Organotypic hippocampal slice culture were treated with LPS for 3 
hr. Gene expressions of IL-1ȕ (a) and TNFĮ (b) were analysed by real time RT-PCR. mRNA expression was normalized 
using GAPDH as an endogenous control. The mean ± S.E.M. of the mRNA expression in each group was calculated and 
then the values are expressed as relative percentages of those in the control group. *p<0.05, **p<0.01 compared with the 
control group.㩷
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slices at 0 and 6 hr after KA treatment. However, a selective 
cell death was seen in pyramidal cell layer of CA3 area at 12 hr, 
and it was detected not only in CA3 area, but also in pyramidal 
cell layer of CA1 area and granular cell layer of DG area at 24, 
36 and 48 hr after KA treatment. Neurotoxicity produced by 
KA was increased in an exposure time-dependent manner. 
 
2. Neuroprotective effects of nicotine and GTS-21 on 
KA-induced neurotoxicity 
Nicotine induced no neurotoxicity up to 10-3 M (data not 
shown). Therefore, we chose nicotine concentration of 10-6, 
10-5 and 10-4 M. Nicotine tended to inhibit KA-induced 
neurotoxicity in a concentration-dependent manner in whole 
hippocampal area. When analysed in CA3 area, pretreatment 
with nicotine resulted in a significant inhibition of KA-induced 
neurotoxicity (Fig. 3). 
  GTS-21 itself showed no neurotoxicity under a long–term 
exposure to hippocampal slice cultures up to 10-4 M (data not 
shown). Pretreatment of slices with 10-6 and 10-5 M of GTS-21 
for 12 hr resulted in a tendency to inhibit KA-induced 
neurotoxicity slightly. When examined CA3 area-specific 
analysis, pretreatment with GTS-21 showed the tendency of 
additional protective effect (Fig. 4).  
 
3. Effects of nicotine and GTS-21 on LPS-induced 
cytokine inductions 
   Inflammatory cytokines mRNA expressions were assessed 
by treatment of hippocampal slices with 1, 10 and 100 ng/mL 
LPS. Marked mRNA expressions of IL-1ȕ and TNFĮ were 
observed in a concentration-dependent manner (Fig. 5). Next, 
we examined the pretreatment effects of nicotine and GTS-21 
on LPS-induced cytokine gene expressions. As shown in Fig. 6, 
both nicotine and GTS-21 failed to inhibit LPS-induced IL-1ȕ 
gene expression (Fig. 6A). On the other hand, pretreatment 
with 10-5 M nicotine and 10-5 M GTS-21 significantly inhibited 
LPS-induced TNFĮ gene expression (Fig. 6B). 
Discussion 
   GTS-21 is an Į7-nAChR agonist synthesized on basis of  
chemical structure of anabasein 13). Anabasein closely 
resembles chemical structure to anabasine, which is a major 
product in tabaco plant Nicotiana glauca cultivated in the 
Eastern Europe. Pharmacological difference between anabasein 
(or anabasine) and nicotine is that the former has high affinity 
to Į7-nAChR than Į4ȕ2-nAChR. However, anabasein also 
stimulates almost all nAChR. Therefore, disubstituted 
benzylidene-anabasein derivatives were developed which 
character had not ganglionic and neuromuscular stimulating 
effects 14). Under a variety of preclinical studies, 2, 
4-dimethoxybenzaldehyde-added anabasein was selected for 
further development, and it is called GTS-21 in code name 17). 
It has a high selectivity for Į7-nAChR as compared to 
anabasein.  
In this study, we examined neuroprotective effects of 
nicotine and GTS-21 on KA-induced neurotoxicity in the 
hippocampal slice cultures. Since KA receptors are distributed 
profoundly in CA3 area rather than CA1 and DG areas of 
juvenile rats 30,31), the nerves in CA3 area are selectively 
vulnerable to KA stimulation, and KA is thought to exert a 
toxic effect selectively on CA3 area 22). Į7-nAChR also 
expresses abundantly in CA3 area of hippocampus 32,33). 
Therefore, we chose KA to examine neuroprotective effects of 
nicotine and GTS-21 in respect of their Į7-nAChR activities.  
When KA at concentration of 5 ~ 50 ȝM added to the 
hippocampal slice cultures, it produced cytotoxic effect on 
hippocampal CA3 area, and its concentrations more than 20 
ȝM resulted in cell death not only CA3 area but also CA1 or 
DG in a concentration-dependent manner. At lower 
concentrations, KA-induced toxicity was observed selectively 
in CA3 area, probable due to be high distribution of KA 
receptors in this area. The findings are also compatible to 
time-dependent toxic effect of KA on CA3 area. Based on these 
findings, we examined possible neuroprotective effects of 
nicotine and GTS-21 on 5 and 10 ȝM KA at which 
concentrations it induces a selective cell death in CA3 area of 
hippocampus. Nicotine has been shown to activate Į7-nAChR 
in the nerve ending of glutamatergic neurons in hippocampus 
and to stimulates a calcium influx into the nerve ending 33). We 
found that the pretreatment with nicotine and GTS-21 tended to 
decrease KA toxicity, especially in CA3 area of hippocampus. 
These results are compatible to many reports indicating that 
nicotine is able to protect effect on KA-induced neurotoxicity 
34,35), probably mediating through Į7-nAChR 36). Chronic 
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㪝㫀㪾㪅㩷㪍㪅㩷 Effects of nicotine and GTS-21 on LPS-induced cytokine inductions. Organotypic hippocampal slice cultures were 
pretreated with 10-5 M nicotine and GTS-21 for 12hr and followed by LPS treatment for 3 hr. Gene expressions of IL-1ȕ (a) 
and TNFĮ (b) were analysed by real time RT-PCR The mean ± S.E.M. of the mRNA expression in each group was 
calculated and then the values are expressed as relative percentages of those in the control group. **p<0.01 compared with 
the control group. #p<0.05 compared with LPS-treated group.㩷
 
exposure of cigarette smoking has also shown to inhibit 
KA-induced neurotoxicity, significantly 37). The present results 
have also revealed that nicotine and GTS-21 suppresses 
KA-induced neurotoxicity in a limited area of hippocampal 
CA3 area. Therefore, it became apparent that neuroprotective 
effect of nicotine and GTS-21 on KA-induced toxicity is 
produced in an area-dependent manner. However, a tendency of 
decrease in KA-induced toxicity by GTS-21 was weak as 
compared to nicotine. The reason comes from the hypothesis 
that since nicotine binds to other nAChR which is found 
extensively in the CNS such as not only Į7-nAChR but 
Į4ȕ2-nAChR, the neuroprotective effect on KA-induced 
toxicity may be produced through Į4ȕ2-nAChR alone or both 
Į4ȕ2-nAChR and Į7-nAChR. Involvement of other nAChR 
remains to be clarified. 
  There are reports that nicotine and GTS-21 showed 
neuroprotective effect on various stimulations including 
glutamate, aspartate, Aȕ peptide, and nerve growth factor 
receptor withdrawal 3,38,39,40). These reports have in common in 
that in order to exert neuroprotective effect, the administration 
of nicotine agonist is required before neurological damage 
occurs by stimulation. Based on this fact, neuroprotective effect 
by nicotine agonist is induced by the mechanism that continued 
over influx of calcium due to calcium influx into cells is 
inhibited 17). On the other hand, co-administration of nicotine 
agonist and neurotoxic substances may result in actually 
excessive influx of calcium into cells than usual. The 
mechanism of this nicotinic neuroprotective effect has not been 
yet completely clarified, therefore, we intend to examine the 
mechanism of action of nicotine and GTS-21 in this field. 
Furthermore, we estimated the effect of nicotine and GTS-21 
by cell death in this study. However, it would be more 
important that we study not only the result of cell death but also 
the process to elucidate the mechanism of neuroprotection. 
   LPS is a polysaccharide which constitutes cell wall of 
gram-negative bacteria, it is an immune cell stimulating 
material known to be an endotoxin 41). Furthermore, LPS 
combines with specifically Toll like receptor 4(TLR4) to 
activate microglia resulting in the release of inflammatory 
cytokines and NO. These reactions are suggested to exert on 
survival or functions of nerve cells 27, 28, 42). In the present study, 
we clarified that both nicotine and GTS-21 were able to inhibit 
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LPS-stimulated TNFĮ gene expressions but not IL-1ȕ. The 
results support the finding that nicotine regulates the release of 
TNFĮ in microglial primary cultured cells 43). Thus, nicotine 
could regulate TNFĮ production at gene level through 
Į7-nAChR in the hippocampal slice cultures. In contrast, lack 
of the inhibitory effects of nicotine and GTS-21 on 
LPS-stimulated IL-1ȕ expression suggest that there exists 
different control mechanism in inflammatory cytokine 
production in microglia. In this respect, further detailed study is 
required. Also, whether the abilities of nicotine and GTS-21 to 
inhibit LPS-induced TNFĮ are really mediated through 
Į7-nAChR remains to be determined. Activation of microglia 
including the release of inflammatory cytokines such as IL-1E 
and TNFҏĮ has also been observed during the development of 
neurodegenerative conditions such as Alzheimer’s and 
Parkinson’s diseases 44). It will be very useful to develop a 
therapeutic drug, which has neuroprotective and 
anti-inflammatory effects via Į7-nAChR for neurodegenerative 
diseases including Alzheimer’s disease.  
   In conclusion, the present study has revealed Į7-nAChR 
agonist, nicotine and GTS-21 are able to inhibit KA-induced 
neurotoxicity and LPS-induced TNFĮ gene expression. 
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ニコチンおよびGTS-21によるａ7ニコチン受容体 
を介した神経保護作用について 
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